ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2015, 'Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study', Australasian Journal of Dermatology, http://dx.doi.org/10.1111/ajd.12295
,2015, 'Welcome to the New International Journal of Women's Dermatology', International Journal of Women's Dermatology, 1, pp. 1, http://dx.doi.org/10.1016/j.ijwd.2014.12.008
,2015, 'Chlorophyll-induced pseudoporphyria with ongoing photosensitivity after cessation - a case series of four patients', Journal of the European Academy of Dermatology and Venereology, pp. n/a - n/a, http://dx.doi.org/10.1111/jdv.13169
,2015, 'Corrélation entre les scores de sévérité clinique (ABSIS, PDAI, PGA), la qualité de vie (DLQI) et les taux d’Ac anti-desmogléine 1 et 3 dans le suivi du pemphigus', Annales de Dermatologie et de Vénéréologie, 142, pp. S444 - S445, http://dx.doi.org/10.1016/j.annder.2015.10.048
,2015, 'Reproductibilité inter-observateur des scores de sévérité du pemphigus ABSIS et PDAI', Annales de Dermatologie et de Vénéréologie, 142, pp. S442 - S443, http://dx.doi.org/10.1016/j.annder.2015.10.047
,2014, 'Screening for infections prior to initiating immunosuppressive treatment for patients with autoimmune blistering diseases', British Journal of Dermatology, 171, pp. 1285 - 1286, http://dx.doi.org/10.1111/bjd.13451
,2014, 'Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: A randomized controlled trial', British Journal of Dermatology, 171, pp. 1164 - 1171, http://dx.doi.org/10.1111/bjd.13138
,2014, 'Diffuse melanosis cutis in the setting of BRAFV600E metastatic melanoma', International Journal of Dermatology, 53, pp. 1409 - 1411, http://dx.doi.org/10.1111/ijd.12614
,2014, 'Management of pemphigus', F1000Prime Reports, 6, http://dx.doi.org/10.12703/P6-32
,2014, 'Dental manifestations of epidermolysis bullosa', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 55, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Oral manifestations and management of dental health in autoimmune blistering diseases', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 55, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400074&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Resolution of chronic multiple verruca vulgaris treated with quadrivalent human papilloma virus (HPV) vaccine', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 55, pp. 17 - 17, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Treatment of autoimmune blistering diseases following the lymphoma protocol for rituximab: A case series of 9 patients', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 55, pp. 22 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes', Journal of Cell Science, 127, pp. 740 - 751, http://dx.doi.org/10.1242/jcs.128454
,2014, 'Dermatology training and practice in Australia', International Journal of Dermatology, 53, pp. 1259 - 1264, http://dx.doi.org/10.1111/ijd.12728
,2014, 'Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)', Journal of the American Academy of Dermatology, 70, http://dx.doi.org/10.1016/j.jaad.2013.09.041
,2014, 'Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering', Journal of Pathology, 232, pp. 541 - 552, http://dx.doi.org/10.1002/path.4323
,2014, 'From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases', Journal of Investigative Dermatology, 134, pp. 2298 - 2300, http://dx.doi.org/10.1038/jid.2014.171
,2014, 'Health-related quality of life in epidermolysis bullosa: Validation of the dutch QOLEB questionnaire and assessment in the dutch population', Acta Dermato-Venereologica, 94, pp. 442 - 447, http://dx.doi.org/10.2340/00015555-1758
,2014, 'Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification', Journal of the American Academy of Dermatology, 70, pp. 1103 - 1126, http://dx.doi.org/10.1016/j.jaad.2014.01.903
,2014, 'Report from the inaugural Australian pruritus symposium, Sydney, Australia, August 10, 2013', Acta Dermato-Venereologica, 94, pp. 123, http://dx.doi.org/10.2340/00015555-1732
,2014, 'Scoring systems for blistering diseases in practice: Why bother, and which one should you use?', JAMA Dermatology, 150, pp. 245 - 247, http://dx.doi.org/10.1001/jamadermatol.2013.8179
,2014, 'Efficacité et tolérance à long terme du vismodégib dans le carcinome baso-cellulaire avancé : analyse finale à 30 mois de l’étude pivotale ERIVANCE', Annales de Dermatologie et de Vénéréologie, 141, pp. S288 - S288, http://dx.doi.org/10.1016/j.annder.2014.09.142
,2014, 'Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering', Journal of Pathology, http://dx.doi.org/10.1002/path.4323
,2014, 'Inherited epidermolysis bullosa', Journal of the Egyptian Womenʼs Dermatologic Society, 11, pp. 1 - 13, http://dx.doi.org/10.1097/01.ewx.0000437657.38804.96
,2013, 'Development of an excel® spreadsheet to document disease activity in autoimmune bullous disease', Acta Dermatovenerologica Croatica, 21, pp. 207 - 208
,2013, 'The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease', British Journal of Dermatology, 169, pp. 1000 - 1006, http://dx.doi.org/10.1111/bjd.12623
,2013, 'A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopy', British Journal of Dermatology, 169, pp. 869 - 879, http://dx.doi.org/10.1111/bjd.12430
,2013, 'Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire', JAMA Dermatology, 149, pp. 1186 - 1191, http://dx.doi.org/10.1001/jamadermatol.2013.4972
,2013, 'Daylight PDT: A Convenient, Similarly Effective, and Nearly Painless Alternative to Conventional PDT', JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 11, pp. 87 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323227600269&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Epidermolysis bullosa pruriginosa triggered by scabies infestation', Journal of Dermatology, 40, pp. 562 - 563, http://dx.doi.org/10.1111/1346-8138.12167
,2013, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study.', Journal of Clinical Oncology, 31, pp. 9037 - 9037, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9037
,2013, 'Cross cultural adaptation of the 'Quality of Life in Epidermolysis Bullosa' (QOLEB) questionnaire: Validation and results of a Hispanic translation', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 39 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Development, reliability and validity of a novel severity score for epidermolysis bullosa: The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Epidemiology of renal impairment in the Australian epidermolysis bullosa population', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Prevalence and characterisation of anaemia in patients with epidermolysis bullosa registered in Australia', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Review of cutaneous outcomes of immunomodulatory drugs for multiple sclerosis', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 49 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine', JAMA Dermatology, 149, pp. 370 - 372, http://dx.doi.org/10.1001/jamadermatol.2013.1463
,2013, 'A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa', Journal of the American Academy of Dermatology, 69, http://dx.doi.org/10.1016/j.jaad.2013.08.014
,2013, 'Bullous pemphigoid: Therapeutic algorithm and practical management', Expert Opinion on Orphan Drugs, 1, pp. 405 - 412, http://dx.doi.org/10.1517/21678707.2013.794693
,2013, 'Management of epidermolysis bullosa', Expert Opinion on Orphan Drugs, 1, pp. 279 - 293, http://dx.doi.org/10.1517/21678707.2013.774274
,2013, 'Measuring quality of life in epidermolysis bullosa in Mexico: Cross-cultural validation of the Hispanic version of the Quality of Life in Epidermolysis Bullosa questionnaire', Journal of the American Academy of Dermatology, 69, pp. 652 - 653, http://dx.doi.org/10.1016/j.jaad.2013.04.053
,2013, 'Successful single-cycle rituximab treatment in a patient with pemphigus vulgaris and squamous cell carcinoma of the tongue and IgG antibodies to desmocollins', Journal of the American Academy of Dermatology, 69, http://dx.doi.org/10.1016/j.jaad.2012.12.967
,2013, 'Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma', British Journal of Dermatology, 169, pp. 208 - 210, http://dx.doi.org/10.1111/bjd.12272
,2013, 'Diffuse melanosis cutis: A systematic review of the literature', Journal of the American Academy of Dermatology, 68, pp. 482 - 488, http://dx.doi.org/10.1016/j.jaad.2012.08.018
,2013, 'Efficacité et tolérance à long terme du vismodegib chez des patients présentant un carcinome basocellulaire avancé (CBCa) : mise à jour à 18 mois de l’étude pivot ERIVANCE CBC', Annales de Dermatologie et de Vénéréologie, 140, pp. S392 - S393, http://dx.doi.org/10.1016/j.annder.2013.09.070
,2013, 'Efficacité et tolérance de la PDT avec Metvix® et lumière du jour dans le traitement des kératoses actiniques : une étude de phase III randomisée, controlée, en simple aveugle', Annales de Dermatologie et de Vénéréologie, 140, pp. S377 - S378, http://dx.doi.org/10.1016/j.annder.2013.09.040
,2013, 'The Pitfalls of Skin Biopsies to Diagnose Epidermolysis Bullosa', Pedatric Dermatology, 30, pp. 273 - 275, http://dx.doi.org/10.1111/pde.120951525-1470
,2013, 'Topically applied flightless i neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita', Journal of Investigative Dermatology, 133, pp. 1008 - 1016, http://dx.doi.org/10.1038/jid.2012.457
,2012, 'Concurrent Management of Toxic Epidermal Necrolysis with Thermal Water Spray and Non-Stick Dressings', Acta Dermatovenerologica Croatica, 20, pp. 210 - 212
,